Metastatic basal cell carcinoma with a high tumor mutational burden that achieved complete response with pembrolizumab

被引：1
|
作者：
Yamakawa, Kohei [1 ]
Ogata, Dai [1 ]
Hiki, Kojiro [1 ]
Jinnai, Shunichi [1 ]
Namikawa, Kenjiro [1 ]
Takahashi, Akira [1 ]
Yamazaki, Naoya [1 ]
机构：
[1] Natl Canc Ctr, Dept Dermatol Oncol, Tokyo, Japan
来源：
INTERNATIONAL JOURNAL OF DERMATOLOGY | 2023年 / 62卷 / 02期
关键词：
D O I：
10.1111/ijd.16245
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：E79 / E80
页数：2
相关论文
共 50 条
  • [41] A rapid and systemic complete response to stereotactic body radiation therapy and pembrolizumab in a patient with metastatic renal cell carcinoma
    Xie, Guozhu
    Gu, Di
    Zhang, Lanfang
    Chen, Shijun
    Wu, Dehua
    CANCER BIOLOGY & THERAPY, 2017, 18 (08) : 547 - 551
  • [42] A rapid and systemic complete response to stereotactic body radiation therapy and pembrolizumab in a patient with metastatic renal cell carcinoma
    Gu, D.
    Xie, G.
    Chen, S.
    Zheng, S.
    INTERNATIONAL JOURNAL OF UROLOGY, 2017, 24 : 92 - 93
  • [43] Pathological Complete Response of Metastatic Clear Cell Renal Carcinoma with Pembrolizumab and Axitinib: A Case Report and Review of Literature
    Beirat, Amir F.
    Menakuru, Sasmith R.
    Khan, Ibrahim
    Siddiqui, Salahuddin
    CASE REPORTS IN ONCOLOGY, 2023, 16 (01): : 30 - 35
  • [44] Tumor mutational burden is predictive of response to immune checkpoint inhibitors in MSI-high metastatic colorectal cancer
    Schrock, A. B.
    Ouyang, C.
    Sandhu, J.
    Sokol, E.
    Jin, D.
    Ross, J. S.
    Miller, A.
    Lim, D.
    Amanam, I
    Chao, J.
    Catenacci, D.
    Cho, M.
    Braiteh, F.
    Klempner, S. J.
    Ali, S. M.
    Fakih, M.
    ANNALS OF ONCOLOGY, 2019, 30 (07) : 1096 - 1103
  • [45] Tumor burden in patients with locally advanced basal cell carcinoma and metastatic basal cell carcinoma following treatment with sonidegib: Results of the 42-month BOLT study
    Migden, Michael
    Farberg, Aaron S.
    Spencer, James
    Kiecker, Felix
    Guminski, Alexander
    Gebauer, Kurt
    Loquai, Carmen
    Robert, Caroline
    Squittieri, Nicholas
    Dummer, Reinhard
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (03) : AB89 - AB89
  • [46] Metastatic / locally advanced Basal cell carcinoma: Association of Vismodegib-Dose and Tumor response
    不详
    OPHTHALMOLOGE, 2014, 111 (04): : 303 - 303
  • [47] Complete pathological response to pembrolizumab in pretreated pancreatic acinar cell carcinoma
    Merz, Valeria
    Maines, Francesca
    Marcucci, Stefano
    Sartori, Chiara
    Frisinghelli, Michela
    Trentin, Chiara
    Kadrija, Dzenete
    Carbone, Francesco Giuseppe
    Michielan, Andrea
    Gabbrielli, Armando
    Melisi, Davide
    Barbareschi, Mattia
    Brolese, Alberto
    Caffo, Orazio
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2024, 150 (07)
  • [48] Tumor Mutational Burden as a Predictor of Survival with Durvalumab and/or Tremelimumab Treatment in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
    Wildsmith, Sophie
    Li, Weimin
    Wu, Song
    Stewart, Ross
    Morsli, Nassim
    Raja, Rajiv
    Zhang, Qu
    Ye, Jiabu
    He, Philip
    Shetty, Jagdish
    Yovine, Alejandro
    Holoweckyj, Nicholas
    Real, Katia
    Walker, Jill
    Wrona, Magdalena
    de los Reyes, Melissa
    Barker, Craig
    Whiteley, Jessica
    Haddad, Robert
    Licitra, Lisa
    Ferris, Robert
    Fayette, Jerome
    Zandberg, Dan P.
    Siu, Lillian L.
    Mesia, Ricard
    CLINICAL CANCER RESEARCH, 2023, 29 (11) : 2066 - 2074
  • [49] Immune Checkpoint Inhibitor Therapy Achieved Complete Response for Drug-Sensitive EGFR/ALK Mutation-Negative Metastatic Pulmonary Large-Cell Neuroendocrine Carcinoma with High Tumor Mutation Burden: A Case Report
    Zhang, Xin
    Sun, Yanbin
    Miao, Yuan
    Xu, Shun
    ONCOTARGETS AND THERAPY, 2020, 13 : 8245 - 8250
  • [50] Pembrolizumab in Patients With Metastatic Breast Cancer With High Tumor Mutational Burden: Results From the Targeted Agent and Profiling Utilization Registry (TAPUR) Study
    Alva, Ajjai S.
    Mangat, Pam K.
    Garrett-Mayer, Elizabeth
    Halabi, Susan
    Hansra, Damien
    Calfa, Carmen J.
    Khalil, Maged F.
    Ahn, Eugene R.
    Cannon, Timothy L.
    Crilley, Pamela
    Fisher, Julie G.
    Haslem, Derrick S.
    Shrestha, Sagun
    Antonelli, Kaitlyn R.
    Butler, Nicole L.
    Warren, Sasha L.
    Rygiel, Andrew L.
    Ranasinghe, Shamika
    Bruinooge, Suanna S.
    Schilsky, Richard L.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (22) : 2443 - +
12345